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The spondylometaphyseal dysplasias (SMDs) are a group of short-stature disorders distinguished by abnormalities in the vertebrae and
the metaphyses of the tubular bones. SMD Kozlowski type (SMDK) is a well-deﬁned autosomal-dominant SMD characterized by signif-
icant scoliosis and mild metaphyseal abnormalities in the pelvis. The vertebrae exhibit platyspondyly and overfaced pedicles similar to
autosomal-dominant brachyolmia, which can result from heterozygosity for activating mutations in the gene encoding TRPV4,
a calcium-permeable ion channel. Mutation analysis in six out of six patients with SMDK demonstrated heterozygosity for missense
mutations in TRPV4, and onemutation, predicting a R594H substitution, was recurrent in four patients. Similar to autosomal-dominant
brachyolmia, the mutations altered basal calcium channel activity in vitro. Metatropic dysplasia is another SMD that has been proposed
to have both clinical and genetic heterogeneity. Patients with the nonlethal form of metatropic dysplasia present with a progressive
scoliosis, widespread metaphyseal involvement of the appendicular skeleton, and carpal ossiﬁcation delay. Because of some similar
radiographic features between SMDK and metatropic dysplasia, TRPV4 was tested as a disease gene for nonlethal metatropic dysplasia.
In two sporadic cases, heterozygosity for de novo missense mutations in TRPV4was found. The ﬁndings demonstrate that mutations in
TRPV4 produce a phenotypic spectrum of skeletal dysplasias from the mild autosomal-dominant brachyolmia to SMDK to autosomal-
dominant metatropic dysplasia, suggesting that these disorders should be grouped into a new bone dysplasia family.Introduction
Spondylometaphyseal dysplasias (SMDs) are characterized
by abnormalities in the vertebrae and the metaphyses of
the tubular bones. There are numerous distinct SMDs,
and classiﬁcation has been based on the severity of the
clinical and radiographic ﬁndings1 and variations in verte-
bral and femoral neck involvement.2 Among these disor-
ders, SMD Kozlowski type ([SMDK]; MIM 1842522) is the
best deﬁned SMD and is inherited in an autosomal-domi-
nant manner.3,4 SMDK is primarily characterized by post-
natal short stature and signiﬁcant kyphoscoliosis leading
to progressive deformity. Other clinical ﬁndings include
normal facies, a short neck, pectus carinatum, and genu
varus.5 Most cases are diagnosed after the age of two
when the patients present with a waddling gait. The radio-
graphic phenotype is distinct and includes odontoid hypo-
plasia, platyspondyly with vertebral bodies described as
resembling an ‘‘open staircase,’’ overfaced vertebral pedi-
cles, short square ilia, ﬂat acetabular roofs, wide proximal
femoral epiphyseal plates, metaphyseal irregularities, and
markedly delayed carpal bone ossiﬁcation.6
Metatropic dysplasia (MIM 156530) was ﬁrst delineated
by Maroteaux et al.7 in 1966, and the name is derivedThe Amerfrom the Greek term metatropos, meaning ‘‘changing
patterns.’’ Genetic heterogeneity based on clinical and
radiographic variability has been proposed,8 including
a nonlethal dominant form and both lethal and nonlethal
autosomal-recessive forms. Other investigators have sug-
gested that all cases represent dominant forms with pheno-
typic variability.9,10 Patients often present with shortened
limbs and a long, narrow trunk in the newborn period
that evolves into a severe, progressive kyphoscoliosis,
frequently requiring surgical correction.11 Affected indi-
viduals have a distinctive facies with a prominent forehead
and squared-off jaw.9 Other signiﬁcant clinical ﬁndings
include a high incidence of odontoid hypoplasia, cervical
myelopathy, and, in some cases, stenosis leading to signif-
icant neurologic sequelae,11,12 as well as respiratory
compromise that can lead to death. Sensorineural deafness
can also occur.9,10 Patients have been described as mani-
festing a coccygeal tail in the newborn period as a result
of excessive ossiﬁcation of the coccyx giving rise to
a bump above the anus. The radiographic ﬁndings inmeta-
tropic dysplasia are characteristic and include wafer-like
vertebral bodies in newborns, a halberd-shaped pelvis,
irregular calcanei and tali, brachydactyly with delayed
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Table 1. Clinical and Radiographic in Findings in Subjects with SMD Kozlowski and Metatropic Dysplasia
Patient R03-404 R97-261 R72-010 R07-490 R07-474 R08-216 R03-386 R00-067
Diagnosis SMDK SMDK SMDK SMDK SMDK SMDK MD MD
Clinical Findings
Age of ascertainment 9 years 8 years 3–6 years 5 years 2.5 years 8 months newborn newborn
High forehead/flat nasal bridge - - - - þ þ þ þ
Hearing loss - - - - - - - NA
Congenital scoliosis NA - þ - þ þ þ þ
Respiratory compromise - - - - - þ/mild þ -
Waddling gait - - þ þ - NA - NA
Contracture - Elbow - - - - þ þ
Prominent joints - - - - - - þ þ
Coccygeal tail* - - - - - * - -
Radiographic Findings
Odontoid hypoplasia - NA NA - - - þ NA
Clavicular pseudoarthrosis þ - - - - - þ -
Anterior rib splaying - NA - - - - þ þ
Platyspondyly mild þ þ þ þ þ þ þ
Dense wafer vertebrae - - - - - - þ þ
Overfaced vertebral pedicles þ þ þ þ þ þ/ - -
Flared iliac wings - mild mild þ þ þ - þ
Halberd pelvis - - mild mild þ þ þ þ
Flat acetabular roof - mild slanted mild - þ þ -
Irregular proximal femoral growth plate þ þ þ þ - þ NA NA
Narrow sacroiliac notches - þ þ þ þ - mild þ
Dumbbell shaped femora/humeri - - - - - - þ þ
Phalangeal cone epiphyses - - - - - - þ þ
Brachydactyly - NA - - - mild þ NA
Carpal ossification delay þ NA þ þ þ NA NA NA
Irregular calcanei/tali - NA NA - - - þ þ
The following abbreviations are used: SMDK, spondylometaphyseal dysplasia, Kozlowski type; MD, metatropic dysplasia; *, sacral dimple; NA*, not appli-
cable because of age or not available; and NA, not applicable or not available.and distal metaphyses of the femora leading to a ‘‘dumb-
bell-shaped bone.’’6
Recently, a form of autosomal-dominant brachyolmia
(MIM 113500) was shown to result from activating muta-
tions in the gene that encodes TRPV413 (MIM 605427),
a calcium-permeable ion channel of the vanilloid subfamily
of TRP channels. Thevertebral body abnormalities (severely
ﬂattened, irregular vertebrae and overfaced pedicles) in
SMDK are similar to those in this form of brachyolmia, sug-
gesting the possibility that the two disorders could be
allelic. In addition, although the appendicular and verte-
bral abnormalities in metatropic dysplasia are much more
severe and distinct from those in SMDK, there was some
similarity in the generalized appearance of the vertebral
bodies, the shape of the pelvis, and the delayed carpal ossi-
ﬁcation. Therefore, TRPV4 was analyzed for mutations in
SMDK and metatropic dysplasia. All six of the SMDK cases
examined were shown to be heterozygous for missense
mutations in TRPV4, as were two cases of metatropic
dysplasia. The SMDK mutations were further shown to
result in altered calcium channel activity in vitro. These
data revealed the molecular basis of SMDK and metatropic
dysplasia and suggest that this group of disorders consti-
tutes a new bone dysplasia family.308 The American Journal of Human Genetics 84, 307–315, MarchMaterial and Methods
Clinical Information
Patients and their families were assessed under an IRB-approved
protocol. The diagnoses of SMDK and metatropic dysplasia were
made based on clinical and radiographic information (Table 1).
Mutation Analysis
Genomic DNA was extracted by standard protocols, and the
coding exons of TRPV4were ampliﬁed by PCR and their sequences
determined as previously described.13 Sequences were compared
to the reference sequence for TRPV4, with nucleotide numbering
starting from the A of the ATG initiation codon.
Expression of Normal and Mutant TRPV4 in HEK293
Cells
Human embryonic kidney cells (HEK293T) were grown in Dulbec-
co’s modiﬁed Eagle’s medium containing 10% (v/v) human serum,
2 mM L-glutamine, 2 U/ml penicillin, and 2 mg/ml streptomycin
at 37C in a humidity-controlled incubator with 10% CO2. As
previously described,13 the cells were transiently transfected
with a human TRPV4 (accession number NP_671737) vector,
cloned as a BamHI fragment into the BcII-site of the pCAGGS
IRES-GFP vector. Mutagenesis and transfection were performed
as previously described.1313, 2009
Electrophysiology
Whole-cell membrane currents were measured with an EPC-10
(HEKA Elektronik, Lambrecht, Germany) with ruptured patches
sampled at 20 kHz and ﬁltered at 2.9 kHz. Patch electrodes had
a direct current (DC) resistance between 2 and 4 MU when ﬁlled
with intracellular solution. AnAg-AgClwire was used as a reference
electrode. Series resistance was compensated (50% and 70%). A
ramp protocol was applied consisting of a voltage step from the
holding potential of 0 mV to –150mV followed by a 400 ms linear
ramp to þ150 mV applied every 2 s. The voltage-step protocol
consisted of 40 ms steps from –80 mV to þ 200 mV. Mean cell-
membrane capacitance was 7.43 5 0.1 picofarads ([pF], n ¼ 58)
and very similar for all HEK cells; therefore, current densities were
not calculated. For electrophysiologicalmeasurements, the standard
extracellular solution contained 150 mM NaCl, 6 mM KCl, 1 mM
MgCl2, 1.5 mM CaCl2, 10 mM glucose, 10 mM HEPES, buffered at
pH 7.4 with NaOH. The osmolality of this solution, measured with
a vapor-pressure osmometer (Wescor 5500, Schlag, Gladbach,
Germany), was 3205 5mOsm. The pipette solutionwas composed
of 20 mM CsCl, 100 mM Asp, 1 mMMgCl2, 10 mM HEPES, 4 mM
Na2ATP, 10 mM BAPTA, 2.93 mM CaCl2, adjusted to pH 7.2 with
CsOH. The free Ca2þ concentration of this solution was 50 nM.
The non-PKC-activating phorbol ester, 4a-phorbol 12,13-dideca-
noate (4a-PDD, Alexis Biochemicals Lausen/Switzerland), was
applied at a 2 mM concentration from a 10 mM stock solution in
ethanol, and arachidonic acid (Sigma)was applied to a ﬁnal concen-
tration of 10 mM. For hypotonic cell swelling, cells were superfused
with a solution containing (in mM) 95 NaCl, 6 CsCl, 1 MgCl2,
1.5 CaCl2, 10 glucose, and 10 HEPES, buffered to pH 7.4 with
NaOH. Iso-osmolarity was achieved by the addition of mannitol
(125 mM) to this solution to reach 320 mOsm. Hypotonic cell
swellingwas induced by the removal ofmannitol to lower the extra-
cellularosmolarity to200mOsm.Allmeasurementswere carriedout
at room temperature, 22C –25C (for additional details, see 13,14).
Intracellular Ca2þ Measurements
Intracellular [Ca2þ]i was measured in Fura-2-loaded cells with
a monochromator-based imaging system.14,15 Ca2þ inﬂuxes were
monitored by CellM imaging software (Olympus, UK) with
OLYMPUS IX81 (Olympus) with standard extracellular solution
similar to that described for electrophysiology.
Results
Clinical
The subjects presented at ages ranging from the newborn
period to age seven. The clinical and radiographic ﬁndings
are summarized in Table 1. Four of the patients diagnosed
with SMDK had typical clinical and radiographic ﬁndings
that included scoliosis and a waddling gait, and radio-
graphic abnormalities including platyspondyly, overfaced
vertebral pedicles, ﬂared iliac wings, a mildly ﬂattened
acetabular roof, irregularproximal capital femoralmetaphy-
ses, a relatively normal appendicular skeleton, and delayed
carpal ossiﬁcation (Figure 1). The mother of case R03-404
was also affected. Two of the SMDK cases (R07-474 and
R08-216) were more severely affected and had some
crossover ﬁndings with metatropic dysplasia, including
a congenital scoliosis, mild facial dysmorphism, andThe Amahalberd-shapedpelvis.These twocasessuggestedapossible
genetic relationship between the SMDK and metatropic
dysplasia and showed the phenotypic continuum between
the disorders. The two metatropic dysplasia cases studied
both had typical clinical and radiographic ﬁndings that
included a high forehead, scoliosis, joint contractures,
odontoid hypoplasia, anterior rib splaying, severe platy-
spondyly, dense vertebral pedicles, a halberd-shaped pelvis,
dumbbell-shaped femora and humeri, cone epiphyses, and
irregularly shaped calcanei and tali (Figure 2).
Mutation Analysis
For testing the hypothesis that SMDK and metatropic
dysplasia could result from TRPV4 mutations, the
sequences of the coding exons were determined in each
case. Heterozygosity for mutations in TRPV4 was found in
all eight patients studied (Table 2). In four patients with
SMDK, R97-261, R72-010, R07-490, and R07-474, a recur-
rent nucleotide substitution c.G1781/A in exon 11, pre-
dicted to lead to the amino acid substitution p.R594H,
was found. In two of these families, R07-490 and R07-474,
this nucleotide substitution was not found in DNA from
the unaffected parents, establishing the change as de
novo (see Figure S1 available online). In SMDK case R03-
404, heterozygosity for a transition, c.A992/G, in exon
6 was identiﬁed, predicting the amino acid substitution
p.D333G. This change was inherited from the subject’s
affected mother. For SMDK case R08-216, heterozygosity
for a transversion, c.G2146/T, was identiﬁed, predicting
the amino acid substitution pA716S. This substitution was
not seen in the parental DNA.
Heterozygosity for mutations in TRPV4 was also found
in the two metatropic dysplasia cases studied, R03-386
and R00-067. These probands were heterozygous for the
nucleotide substitutions c.C2396/T and c.A991/T, pre-
dicting the amino acid substitutions, p.P799L and
p.I331F, respectively (see Figure S1). In both cases, these
substitutions were not found in DNA from the unaffected
parents. The predicted amino acid substitutions identiﬁed
in all of the SMDK and metatropic dysplasia cases occurred
in residues that have been highly conserved through
evolution (Homo sapiens through C. elegans), further sup-
porting their pathogenicity. Furthermore, none of the
sequence changes were found among at least 214 control
chromosomes, indicating that none are common poly-
morphisms in the population16 and consistent with each
change being causative.
Ca2þ Measurements and Electrophysiology
For determination of the effect of the SMDK mutations on
TRPV4 activity, normal andmutant human TRPV4were ex-
pressed in HEK cells.13 In comparison to wild-type TRPV4,
the D333G and R594H mutations yielded much larger
constitutive currents before agonist application (Figure 3A–
3C and 3E). This was conﬁrmed in whole-cell current
measurements showing robust basal currents for the
D333G and R594H mutants (Figure 3E). The basal currentserican Journal of Human Genetics 84, 307–315, March 13, 2009 309
were blocked in a voltage-dependent manner by the TRPV4
blocker ruthenium red (data not shown). The shape of the
IV curve and the reversal potentials were not changed for
the D333G and R594H mutants (see Figure S2A). The
increased nonstimulated channel activity was also observed
in calcium-imaging experiments on intact cells (Figure 4).
The basal Fura-2 ﬂuorescence ratio, which reﬂects basal
[Ca2þ]i anddependsonCa2þ inﬂux,was signiﬁcantlyhigher
in cells expressing theD333G andR594Hmutations than in
those expressing wild-type (WT) TRPV4 (Figure 4E).
The mutations also affected the responses to the TRPV4-
speciﬁc agonist 4aPDD (Figures 4A–4C, and 4F), and
Figure S2D). The R594H mutant was fully insensitive to
4aPDD stimulation, whereas the response of the D333G
mutant was signiﬁcantly increased when compared with
WT TRPV4. However, reduced current and Ca2þ responses
were measured upon stimulation with hypotonic solution
(reduction of extracellular osmolarity from 320 to 200
mOsm) or by application of 10 mM arachidonic acid (AA)
(Figure 4 and Figures S2 and S3). It is possible that the
reduced response of these channels to agonist or mechan-
ical stimulation reﬂects basal activities that approach
maximal channel activation.
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Figure 1. Radiographs of Individuals with
SMDK with TRPV4 Mutations
Reference numbers are indicated above each
column of radiographs. The ages of the subjects
were 5 years (R07-490), 3 years (R72-010), 9 years
(R03-404), and 8 months (R08-216).
(A–D) Anteroposterior (A/P) radiographs of the
chest in four subjects, demonstrating the vari-
ability of the scoliosis from mild to more severe.
The arrow in (C) shows the overfaced pedicles
(lamina are seen medial to the vertebral edge).
(E–G) Lateral radiographs of the vertebrae showing
flattened vertebrae (platyspondyly) and irregular
margins.
(H) Lateral radiograph of the cervical vertebrae
showing a small, irregular C1 vertebra (odontoid
hypoplasia, arrow), a finding similar to metatropic
dysplasia.
(I–K) A/P radiographs of the pelvis showing
slightly flared ilia, wide epiphyseal plates, and
mildly irregular acetabulae (arrows).
(L) A/P radiograph of lower extremity showing
slightlywidenedmetaphyseswithnormal epiphyses,
somewhat reminiscent of metatropic dysplasia.
(M–P) A/P hand radiographs demonstrating the
marked carpal ossification delay (arrows) for each
subject’s respective age.
In contrast, the A716S mutation showed
a similar basal activity as WT TRPV4
(Figures 3D and 3E). However, calcium-
imaging experiments and electrophysiolog-
ical recordings performed on A716S trans-
fected HEK cells showed that this mutant
was fully unresponsive to stimulation by 4aPDD (Figures
4D and 4F, and Figures S2A and S2D), cell swelling
(Figure 4G and Figures S2B and S3D) and AA (Figure 4G
and Figures S2C and S3H). Two lines of evidence indicate
that the lack of response to TRPV4-activating stimuli in
thismutant was not due to an effect on channel expression
or protein targeting to the membrane. First, HEK cells ex-
pressing the A716 mutant exhibited increased basal
currents and intracellular Ca2þ levels when compared to
nontransfected HEK cells, indicating that the channel is
functional (Figure 4E). Second, cell-surface biotinylation
assays did not reveal signiﬁcant differences in the level of
TRPV4 at the plasma membrane between cells expressing
mutant and WT TRPV4 (data not shown).
Discussion
In mammals, the transient receptor potential (TRP) super-
family consists of 28 cation channels that are permeable
to bothmonovalent and divalent cations.17–19 These chan-
nels play a key role in ion homeostasis and are unique
cellular sensors that function as important integrators of
sensory information required for taste, vision, nociception,310 The American Journal of Human Genetics 84, 307–315, March 13, 2009
and the detection of temperature and mechanical
forces.20,21 TRPV4 is involved in promoting regulatory-
volume decrease by sensing a hypotonic stimulus and
mediating the inﬂux of extracellular calcium that then acti-
vates pathways leading to the secretion of Kþ and Cl, fol-
lowed by the loss of intracellular water.22–24 Additionally,
channel activity appears to be regulated by a calmodulin-
dependent mechanism with negative feedback loops.
The TRPV4 molecule is composed of three ankyrin
repeats located at the amino terminus and six putative
transmembrane domains with a cation-permeable pore
region located between transmembrane domains 5 and
Figure 2. Radiographs of Metatropic
Dysplasia in the Newborn Period
Reference numbers for the cases are indicated on
each image.
(A and C) Body A/P radiographs in two cases
showing severe platyspondyly (wafer-like), ante-
rior and posterior rib cupping, widened ileum,
and markedly flared proximal and distal femoral
metaphyses (dumbbell-shaped femora).
(B) Lateral cervical spine radiograph demon-
strating odontoid hypoplasia and hypoplasia of
the cervical vertebral bodies with cervical
kyphosis (arrows).
(D and E) Lateral lower-extremity radiograph
showing characteristic irregular tali and calcanei
(arrows) frequently seen in metatropic dysplasia.
(F) A/P radiograph of the upper extremity showing
highly irregular metaphyses with popcorn appear-
ance (arrow).
625–27 (TM5 and TM6; Figure 5). Heterozy-
gosity for mutations in TRPV4 produces
autosomal-dominant brachyolmia, a rela-
tivelymild skeletal dysplasia, primarily char-
acterized by modest short-trunk short
stature, scoliosis, and platyspondyly with
overfaced vertebral pedicles apparent on
radiographs.13,28 To date, two missense
mutations that reside within the TM5
domain, R616Q and V620I (Figure 5), have
been found to produce the disorder. Patch-clamp experi-
ments using transfected HEK cells showed that both muta-
tions resulted in a signiﬁcant gain of function characterized
by increased constitutive activity and elevated channel
activationby a variety ofmechanisms includingmechanos-
timulation, and agonist stimulation by arachidonic acid
and the TRPV4-speciﬁc agonist 4a-phorbol 12,13-dideca-
noate (4aPDD).13 The mutations are localized at the
cytoplasmic end of TM5, a region that has been recently
discussed as part of a ‘‘hand-handle’’ domain transferring
a gating signal from the TM1-TM4 unit to the TM5-TM6
pore unit.29 It thus appears that, in brachyolmia, theTable 2. Summary of Mutations and Their Effect on TRPV4
Patient Diagnosis TRPV4 Exon
Nucleotide
Substitution
Predicted Amino
Acid Change Protein Domain
Basal [Ca2þ]i
Intracellular Activity
R03-404 SMDK 6 cA992/G p.D333G ANK5 [
R72-010 SMDK 11 c.G1781/A p.R594H cytoplasmic/S4 [
R97-261 SMDK 11 c.G1781/A p.R594H cytoplasmic/S4 [
R07-490 SMDK 11 c.G1781/A p.R594H cytoplasmic/S4 [
R07-474 SMDK 11 c.G1781/A p.R594H cytoplasmic/S4 [
R08-216 SMDK 13 c.G2146/T p.A716S cytoplasmic/S6 Same as WT
R00-067 Metatropic 6 c.A1080/T p.I331F ANK5 unknown
R03-386 Metatropic 15 c.C2396/T p.P799L cytoplasmic unknown
The following abbreviations are used: SMDK, spondlyometaphsyeal dysplasia; c, nucleotide; p, protein; ANK, anykrin; S, transmembrane domain;
[, increased; and WT, wild-type.The American Journal of Human Genetics 84, 307–315, March 13, 2009 311
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Figure 3. Basal Activity of TRPV4 Wild-Type and TRPV4 Mutants
(A–D) Basal currents through wild-type TRPV4 (A), D333G (B), R594H (C), and A716S (D) transfected HEK cells in response to a voltage
step protocol (40 mV steps from –80 mV to þ200 mV).
(E) Average basal inward and outward currents at –150 and þ150 mV in wild-type TRPV4 (n ¼ 8), D333G (n ¼ 12), R594H (n ¼ 16) and
A716S (n ¼ 9) expressing HEK cells. * indicates significant differences when compared with cells expressing wild-type TRPV4 (one-sided
Student’s t test, p < 0.05). Error bars represent means5 SE (standard error).stimuli. Cells expressing the R594A substitution wereprimary consequence of these mutations is to increase
intracellular calcium via increased channel activity.
SMDK shares some features with autosomal-dominant
brachyolmia, including scoliosis, platyspondyly, and the
radiographic appearance of the vertebral bodies. However,
the skeletal phenotype of SMDK ismore severe than that of
brachyolmia, especially the spinal changes. Relative to bra-
chyolmia, SMDK patients exhibit more signiﬁcant short
stature over time, have odontoid hypoplasia, more severe
metaphyseal changes in the appendicular skeleton, and
carpal ossiﬁcation delay. One of the unexpected clinical
ﬁndings in the cohort of patients described in this study
was that three out of six patients presented with congenital
scoliosis, questioning the original literature suggesting
that SMDK patients typically present with a waddling
gait and scoliosis around age two.3 In addition, there was
signiﬁcant phenotypic variability within the SMDK
cohort. Among the four patients harboring the R594H
mutation, there was a spectrum in the degree of spinal
abnormalities and one patient, R07-474, had radiographic
abnormalities that had some overlapping ﬁndings with312 The American Journal of Human Genetics 84, 307–315, Marchmetatropic dysplasia. Thus it is difﬁcult to establish a direct
relationship between mutation and phenotype.
In contrast to the brachyolmia cases, the TRPV4 muta-
tions found in SMDK did not alter TM5. Two mutations,
D333G and A716S, were found to alter cytoplasmic
portions of the molecule (Figure 5), the functions of which
have not been determined to date. D333 is located in the
ankyrin repeat domains of TRPV4, a region considered to
act as a putative binding region for other regulatory
proteins.25 The cytoskeletal organizer Pacsin 3 binds to
the N terminus of TRPV4, thereby modulating its activa-
tion modes.30 Therefore, it is possible that mutations in
this region could render the channel nonresponsive to
important protein-protein interactions.
There was one recurrent mutation, R594H, that occurred
independently in four cases, revealing a mutational hot-
spot within the gene. This speciﬁc amino acid, arginine
594, is highly conserved among the members of the
TRPV subfamily of TRP channels and has been found to
be critical for the detection and transduction of chemical
1413, 2009
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Figure 4. Effect of TRPV4 Mutagenesis on Activation of TRPV4 by Different Activation Stimuli
(A–D) Effect of stimulation with 2 mM 4aPDD on internal fluorescence ratio in wild-type TRPV4 (A), D333G (B), R594H (C), and A716S
(D) transfected HEK cells.
(E) Basal internal fluorescence ratio, which is a reference for the basal [Ca2þ]i, in nontransfected (NT) and the wild-type TRPV4 and TRPV4
mutant transfected cells, D333G, R594H, and A716S.
(F–H) Average increase in fluorescence ratio in response to 4aPDD (2 mM) (F), a hypotonic stimulus (HTS) (G), and 10 mM arachidonic acid
(AA) (H). For every condition, n > 24 in at least three independent recordings. * indicates significant differences when compared with
cells expressing wild-type TRPV4 (one-sided Student’s t test, p < 0.05). Error bars represent means5 SE.unresponsive to chemical stimulation but remained
responsive to heat stimulation. Other amino acid substitu-
tions, R594Q and R594L, showed varying responses to
stimuli and it appears that a charged residue is needed to
detect and transduce stimuli.14 Patch-clamp experiments
using HEK cells expressing the R594H SMDK mutation
showed increased constitutive and agonist-responsive
TRPV4 activity similar to what was found for the brachyol-
mia mutations. The D333G substitution also increased the
level of constitutive channel activity and responded to
additional stimulation. Thus, similar to mutations found
in autosomal-dominant brachyolmia, these two SMDK
Figure 5. Diagram of the TRPV4 Molecule
The locations of the mutations relative to the domains of the molecule for autosomal-dominant brachyolmia, spondylometaphyseal
dysplasia, Kozlowski type, and metatropic dysplasia.The American Journal of Human Genetics 84, 307–315, March 13, 2009 313
St
m
a
S
S
t
A
T
i
s
g
F
z
P
i
R
R
R
A
P
W
T
O
Rmutations probably produce disease by resulting in a net
increase in intracellular calcium in chondrocytes.
However, the relevant TRPV4-activating stumuli in chon-
drocytes is unknown.
Although expression of the carboxyl-terminal A716S
mutationdidproduce a slightly increasedbasal intracellular
Ca2þ concentration, this mutant had diminished channel
activity relative to the other mutations under both basal
and stimulated conditions. The properties of this channel
suggest that the increased basal Ca2þ level conferred by
the mutation, rather than an increased channel response
upon stimulation, may be the key factor in producing
disease.However it is alsopossible that thismutation causes
disease by a completely different mechanism.
Metatropic dysplasia has been viewed as genetically
complex because of the broad range of clinical severity
and the possibility of different patterns of inheritance,
with both autosomal-dominant and -recessive forms
proposed. The hypothesis that metatropic dysplasia could
be allelic to SMDK was suggested by phenotypic ﬁndings
of severe platyspondyly, anoften relentless scoliosis, a ﬂared
ileum, and carpal ossiﬁcation delay. In two cases with char-
acteristic ﬁndings of the nonlethal dominant form ofmeta-
tropic dysplasia that included congenital scoliosis, a long
narrow thorax, dense wafer-like vertebral bodies, and
delayed carpal ossiﬁcation, mutations in TRPV4 were iden-
tiﬁed. The two missense mutations, predicting I331F and
P779L substitutions, altered cytoplasmic residues at the
amino and carboxyl termini of the molecule, respectively
(Figure 5). The more amino-terminal substitution, I331F,
lies between the fourth and ﬁfth ankryin repeats, and the
more carboxyl-terminal mutation, P799L, is near the puta-
tive calmodulin-binding domain at residues 812–831.
However, despite the proximity of these amino acids to
established domains in TRPV4, the biological function of
these residues is largely unknown. Because only two meta-
tropic dysplasia cases were studied, it remains possible that
mutations inother genescould alsoproduce thephenotype.
Mutations in TRPV4 have now been identiﬁed in three
dominantly inherited skeletal phenotypes, autosomal-
dominant brachyolmia, SMDK and metatropic dysplasia,
revealing a critical role for the molecule in the growth
plate. The abnormalities in brachyolmia and SMDK imply
abnormalities in growth-plate chondrocyte differentiation
in the vertebrae and long bones. The more severe meta-
tropic dysplasia phenotype, which by contrast with
SMDK includes increased mineralization of the vertebrae,
suggests possible involvement of both cartilage and
bone. Recently, a role for TRPV4 in bone has been eluci-
dated on the basis of the observation that inactivation of
Trpv4 in mice leads to a defect in osteoclast differentiation
and overmineralized bone.31 The relationship between
these ﬁndings and the phenotypes andmechanisms result-
ing from altered TRPV4 remains to be deﬁned.
The ﬁndings in this study demonstrate that mutations in
TRPV4 produce a phenotypic spectrum of autosomal-
dominant skeletal dysplasias from mild brachyolmia to314 The American Journal of Human Genetics 84, 307–315, March 13MDK to metatropic dysplasia. The overlapping pheno-
ypic ﬁndings among the patients and the allelic series of
utations in TRPV4 suggest that these disorders comprise
new bone dysplasia family.
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